Clinical Trials Browser

Phase 1 × copper dotatate CU-64 × Clear all

NCT06379217 2026-03-11

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Phase 1 Active not recruiting

EndocrineGenitourinary

Metastatic Neuroendocrine Prostate Cancer

NCT07150546 2026-03-02

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Phase 1 Recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor